Adam D Scott
Adam D Scott
Geverifieerd e-mailadres voor wustl.edu
Titel
Geciteerd door
Geciteerd door
Jaar
Pathogenic germline variants in 10,389 adult cancers
K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ...
Cell 173 (2), 355-370. e14, 2018
3262018
Protein-structure-guided discovery of functional mutations across 19 cancer types
B Niu, AD Scott, S Sengupta, MH Bailey, P Batra, J Ning, ...
Nature genetics 48 (8), 827-837, 2016
1062016
Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
K Huang, S Li, P Mertins, S Cao, HP Gunawardena, KV Ruggles, ...
Nature communications 8 (1), 1-17, 2017
922017
Systematic discovery of complex insertions and deletions in human cancers
K Ye, J Wang, R Jayasinghe, EW Lameijer, JF McMichael, J Ning, ...
Nature medicine 22 (1), 97-104, 2016
852016
A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-β superfamily
A Korkut, S Zaidi, RS Kanchi, S Rao, NR Gough, A Schultz, X Li, ...
Cell systems 7 (4), 422-437. e7, 2018
642018
Database of evidence for precision oncology portal
SQ Sun, RJ Mashl, S Sengupta, AD Scott, W Wang, P Batra, LB Wang, ...
Bioinformatics 34 (24), 4315-4317, 2018
212018
GenomeVIP: a cloud platform for genomic variant discovery and interpretation
RJ Mashl, AD Scott, K Huang, MA Wyczalkowski, CJ Yoon, B Niu, ...
Genome research 27 (8), 1450-1459, 2017
162017
CharGer: clinical Characterization of Germline variants
AD Scott, KL Huang, A Weerasinghe, RJ Mashl, Q Gao, ...
Bioinformatics 35 (5), 865-867, 2019
132019
Clustering and phase transitions on a neutral landscape
AD Scott, DM King, N Marić, S Bahar
EPL (Europhysics Letters) 102 (6), 68003, 2013
92013
Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun 8: 14864
KL Huang, S Li, P Mertins, S Cao, HP Gunawardena, KV Ruggles, ...
62017
Stopping discrimination before it starts: the impact of civil rights laws on healthcare disparities-a medical school curriculum
S Bereknyei, S Foran, K Johnson, A Scott, T Miller, C Braddock III
MedEdPORTAL Publications 5, 7740, 2009
62009
Multiple phase transitions in an agent-based evolutionary model with neutral fitness
DM King, AD Scott, S Bahar
Royal Society Open Science 4 (4), 2017
52017
Regulated phosphosignaling associated with breast cancer subtypes and druggability
K Huang, Y Wu, T Primeau, YT Wang, Y Gao, JF McMichael, AD Scott, ...
Molecular & Cellular Proteomics 18 (8), 1630-1650, 2019
42019
Speciation dynamics of an agent-based evolution model in phenotype space
AD Scott
Missouri University of Science and Technology, 2014
42014
Pathogenic Germline Variants in 10,389 Adult Cancers
RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, S Reynolds, ...
Cell 173 (2), 2018
22018
Corrigendum: Protein-structure-guided discovery of functional mutations across 19 cancer types
B Niu, AD Scott, S Sengupta, MH Bailey, P Batra, J Ning, ...
Nature genetics 49 (8), 1286, 2017
12017
Sequence and structure-guided approach to identify functional mutations in G-protein coupled receptors
S Sengupta, K Ye, AD Scott, B Niu, MH Bailey, MD McLellan, MC Wendl, ...
Cancer Research 75 (15 Supplement), 61-61, 2015
12015
Characterizing Phase Transitions in a Model of Neutral Evolutionary Dynamics
A Scott, D King, S Bahar
APS March Meeting Abstracts 2013, C44. 003, 2013
12013
Spatially interacting phosphorylation sites and mutations in cancer
K Huang, AD Scott, DC Zhou, LB Wang, A Weerasinghe, A Elmas, R Liu, ...
Nature communications 12 (1), 1-13, 2021
2021
Characterization of Germline Variants in Multiple Myeloma
F Martins Rodrigues, Q Gao, K Huang, AD Scott, SM Foltz, J King, ...
Blood 132 (Supplement 1), 4499-4499, 2018
2018
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20